Eamonn Richard Maher
Impact in
- Cancer Research top 0.02%
- Cancer, Hypoxia, and Metabolism
- Genetics top 0.05%
- Genetic Syndromes and Imprinting
Papers in
- Cancer Research 131
- Cancer, Hypoxia, and Metabolism 103
- Genetics 151
- Genetic Syndromes and Imprinting 71
- Co-authors
- Farida Latif (81 shared papers)Peter John Ratcliffe (8 shared papers)Steven C. Clifford (9 shared papers)Patrick Henry Maxwell (7 shared papers)Christopher William Pugh (4 shared papers)Gin-Wen Chang (2 shared papers)Matthew E. Cockman (2 shared papers)Michael Sean Wiesener (8 shared papers)
- Journals
- Journal of Medical Genetics (39 papers)Human Molecular Genetics (26 papers)Oncogene (22 papers)The American Journal of Human Genetics (21 papers)European Journal of Human Genetics (18 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Eamonn Richard Maher
546 papers receiving 51.1k citations
Eamonn Richard Maher's Hit Papers
Peers
Comparison fields: 5 of 183
- Cancer Research 15.2k
- Genetics 12.0k
- Molecular Biology 24.6k
- Pediatrics, Perinatology and Child Health 4.9k
- Pulmonary and Respiratory Medicine 8.0k
Countries citing papers authored by Eamonn Richard Maher
This map shows the geographic impact of Eamonn Richard Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eamonn Richard Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eamonn Richard Maher more than expected).
Fields of papers citing papers by Eamonn Richard Maher
This network shows the impact of papers produced by Eamonn Richard Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eamonn Richard Maher. The network helps show where Eamonn Richard Maher may publish in the future.
Co-authors
The 25 scholars most cited alongside Eamonn Richard Maher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 562 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Hit paper breakdown → | 1999 | 4413 |
| 2 | Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene Hit paper breakdown → | 1993 | 2409 |
| 3 | Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein Hit paper breakdown → | 2000 | 910 |
| 4 | Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial Hit paper breakdown → | 2011 | 776 |
| 5 | Clinical Features and Natural History of von Hippel-Lindau Disease Hit paper breakdown → | 1990 | 765 |
| 6 | Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome Hit paper breakdown → | 2002 | 724 |
| 7 | VHL, the story of a tumour suppressor gene Hit paper breakdown → | 2014 | 610 |
| 8 | Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study Hit paper breakdown → | 2019 | 506 |
| 9 | 2011 | 498 | |
| 10 | Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition Hit paper breakdown → | 2016 | 483 |
| 11 | 2008 | 482 | |
| 12 | 2003 | 471 | |
| 13 | 2006 | 459 | |
| 14 | 1991 | 455 | |
| 15 | 2002 | 438 | |
| 16 | An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis Hit paper breakdown → | 2009 | 435 |
| 17 | 1996 | 426 | |
| 18 | 2009 | 416 | |
| 19 | Familial gastric cancer: overview and guidelines for management. | 1999 | 410 |
| 20 | Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement Hit paper breakdown → | 2018 | 397 |
About Eamonn Richard Maher
Eamonn Richard Maher is a scholar working on Cancer Research, Genetics, Molecular Biology, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine, having authored 562 papers that have together received 53.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (115 papers), Cancer, Hypoxia, and Metabolism (103 papers), Genetic Syndromes and Imprinting (71 papers), Adrenal and Paraganglionic Tumors (65 papers), Renal and related cancers (64 papers), Renal cell carcinoma treatment (62 papers), Genetic factors in colorectal cancer (46 papers) and Prenatal Screening and Diagnostics (45 papers). The work is most often cited by research in Cancer Research (15.2k citations), Genetics (12.0k citations), Molecular Biology (24.6k citations), Pediatrics, Perinatology and Child Health (4.9k citations) and Pulmonary and Respiratory Medicine (8.0k citations). Eamonn Richard Maher has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Farida Latif, Peter John Ratcliffe, Steven C. Clifford, Patrick Henry Maxwell, Christopher William Pugh, Gin-Wen Chang, Matthew E. Cockman, Michael Sean Wiesener, Charles C. Wykoff and Wolf Reik. Their work appears in journals such as Journal of Medical Genetics, Human Molecular Genetics, Oncogene, The American Journal of Human Genetics and European Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.